Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compound annual growth rate (CAGR) of ~5.2% from 2020.
The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment.
While Europe is the highest contributor to the total market, Asia-Pacific (APAC) is expected to witness the highest growth during the forecast period (2020 to 2026) of this research. This market will be driven further by innovation in targeted therapeutic applications, high sample utilization of tissue/stem cells, and the increasing demand for bio-data for enabling patient stratification. Significant growth opportunities for biobanks are in the areas of companion diagnostics (CDx) co-development, large-scale genome sequencing projects, immuno-oncology clinical development, digital pathology services, and real-world evidence (RWE) studies.
The shifting industry paradigm towards commercial partnerships with pharmaceutical and biotech companies, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs), as well as diagnostics and digital solution providers is expected to further boost market growth. Biobanks are partnering with end-users for customized research-based engagements as niche providers of samples and services and as data owners. However, they need to better understand the changing end-user needs and transition to innovative value-based data pricing and hybrid models for ensuring operational sustainability in the future.
Collaborations with commercial partners by fulfilling key selection criteria and engaging with well-defined models are a critical requirement for biobanks to retain market share. A number of leading biobanks in the United States, the United Kingdom, Sweden, and Denmark have taken major strides in adopting and implementing industry best practices in the last few years.
Key Topics Covered:
1. Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8
The Impact of the Top Five Strategic Imperatives on the Biobanking Industry
Growth Opportunities Fuel the Growth Pipeline Engine
2. Growth Opportunity Analysis, Biobanking Market
Biobanking Market, Scope of Analysis
Biobanking Market, Scope of Analysis - COVID-19 Impact
Biobanking Market, Scope of Analysis - Key Market Themes
Biobanking Market, Scope of Analysis - Value Chain & Key Stakeholders
Biobanking Market, Scope of Analysis - Workflow Optimization
Biobanking Market, Scope of Analysis - Future Role of Biobanks
Biobanking Market, Segmentation
Key Competitors and End-users in the Biobanking Market
Key Growth Metrics for the Biobanking Market
Growth Drivers for the Biobanking Market
Growth Driver Analysis for the Biobanking Market
Growth Restraints for the Biobanking Market
Growth Restraint Analysis for the Biobanking Market
Market Forecast Assumptions, Methodology - Biobanking Market
Revenue Forecast, Biobanking Market
Revenue Forecast Analysis by Region, Biobanking Market
Revenue Forecast by Application
Percent Revenue Share by Application
Revenue Forecast by Biobank Type
Percent Revenue Share by Biobank Type
Revenue Forecast by Sample Type
Percent Revenue Share by Sample Type
Revenue Forecast by Ownership Type
Percent Revenue Share by Ownership Type
Stakeholder Engagement, Biobanking Market
Pricing Analysis, Biobanking Market
End-user Analysis, Biobanking Market
Competitive Environment, Biobanking Market
3. Growth Opportunity Universe, Biobanking Market
Top 5 Growth Opportunities
Growth Opportunity 1: Companion Diagnostics Co-Development for Biomarker-based Therapeutics, 2020
Growth Opportunity 1: Companion Diagnostics Co-Development Analysis, 2020
Growth Opportunity 2: Bio-data for Large-scale Genome Sequencing Projects, 2020
Growth Opportunity 2: Large-scale Genome Sequencing Analysis, 2020
Growth Opportunity 3: Human Tissue/Tumor Cells for Oncology Clinical Development, 2020
Growth Opportunity 3: Oncology Clinical Development Analysis, 2020
Growth Opportunity 4: Digital Pathology and Imaging Services, 2020
Growth Opportunity 4: Digital Pathology and Imaging Analysis, 2020
Growth Opportunity 5: RWE Studies for Product Commercialization, 2020
Growth Opportunity 5: RWE Analysis, 2020
4. Next Steps
For more information about this report visit https://www.researchandmarkets.com/r/ueizdq
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900